This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
CF Industries (CF) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
CF Industries' (CF) fourth-quarter performance is likely to reflect higher nitrogen demand, lower natural gas costs and weak nitrogen pricing.
Albemarle (ALB) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from cost-saving initiatives in Q4. However, weak lithium prices and soft demand in certain markets are likely to have affected performance.
Albemarle (ALB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Albemarle (ALB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $158.69 in the latest trading session, marking a -1.78% move from the prior day.
Can Albemarle (ALB) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Albemarle (ALB) Issues Q4 Preliminary Results, Provides FY21 View
by Zacks Equity Research
Albemarle (ALB) expects adjusted EPS in the range of $1.11-$1.19 for Q4.
Albemarle (ALB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $169.25, marking a +1.73% move from the previous day.
OLN vs. ALB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
OLN vs. ALB: Which Stock Is the Better Value Option?
Albemarle (ALB) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $176.92, moving +1.85% from the previous trading session.
Albemarle (ALB) Expands Nevada Site to Boost Lithium Production
by Zacks Equity Research
Albemarle (ALB) to expand production capacity at its Nevada site to meet high demand for domestic lithium supply.
OLN or ALB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
OLN vs. ALB: Which Stock Is the Better Value Option?
10 Top-Performing Stocks of the S&P 500 ETF in 2020
by Sanghamitra Saha
If a Santa Claus rally grips Wall Street in the final days of December, the S&P 500 could see smart gains in 2020 despite the COVID-19 outbreak. These stocks helped the index to hit highs this year.
4 Diversified Chemical Stocks Set to Ride the Industry's Upturn
by Anindya Barman
An uptick in demand in key end-markets from pandemic-led shocks should enable the Zacks Chemicals Diversified industry to thrive. PPG, CC, CBT and KOP are set to gain from improving industry fundamentals and strategic actions.
Batteries Serve as 'Secret Sauce' for EVs: 4 Stocks in Focus
by Rimmi Singhi
Widespread adoption of EVs will have a trickle-down effect in the supply chain, making battery-related stocks more attractive than ever. PCRFY, ENS, ALB and VALE are likely to cash in on the EV boom.
3 Lithium Stocks to Power Your Portfolio in 2021
by Rimmi Singhi
The lithium market shines brighter than ever, thanks to the EV boom. With all automakers revving up their electrification goals, key lithium players like ALB, LAC and PLL seem promising bets.
EV Sales May Rise 50% in 2021: 3 Utilities Likely to Gain
by Aparajita Dutta
In the United States, 45 utilities have approval to invest nearly $1.5 billion in electric vehicle (EV) charging programs. Investors may keep a watch on PCG, EIX, and DUK.
Albemarle (ALB) Up 24.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Albemarle (ALB) Q3 Earnings and Revenues Trounce Estimates
by Zacks Equity Research
Albemarle (ALB) saw lower sales across its segments in the third quarter. It expects to realize around $80 million of cost savings in 2020.
Albemarle (ALB) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 39.74% and 1.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Barrick (GOLD) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Barrick's (GOLD) Q3 performance is likely to reflect the benefits of higher gold prices.
Kinross (KGC) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Kinross' (KGC) third-quarter 2020 performance is likely to reflect the benefits of higher gold prices.
CF Industries (CF) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of higher demand and lower natural gas costs are likely to get reflected in CF Industries' (CF) Q3 results. However, lower nitrogen pricing is likely to have weighed on margins.
WestRock (WRK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
WestRock's (WRK) Q4 results likely to reflect gains from investments, acquisitions as well as productivity and performance-improvement programs.
First Majestic (AG) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
First Majestic's (AG) July-September quarter results are likely to reflect the impact of increasing silver and gold prices as well as higher production numbers.
Albemarle (ALB) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of cost-saving initiatives are expected to get reflected on Albemarle's (ALB) Q3 results.